Asston Pharmaceuticals Limited engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia. It offers medicine for the treatment of anti-inflammatory, over-the-counter, swelling, stiffness, relieve and joint pain, tenderness, intestinal, acidity and indigestion, toothache, muscle pain, fever and rheumatic pain, common cold and allergy, malaria infections, folic acid deficiency, iron deficiency anemia, anemia, bacterial infections, and fungal skin infections, as well as drugs for various parasitic worm infection and ailments in babies. The company also provides vitamin and mineral, hormonal balance, and dietary supplements. It sells its products in the form of tablets, capsules, oral liquid, ointment, cream, gel and lotion, and oral powder under the Asston brand. The company was incorporated in 2019 and is based in Navi Mumbai, India.
Metrics to compare | ASSN | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipASSNPeersSector | |
---|---|---|---|---|
P/E Ratio | 21.1x | 10.8x | −0.5x | |
PEG Ratio | 0.11 | 0.14 | 0.00 | |
Price/Book | - | 1.2x | 2.6x | |
Price / LTM Sales | 3.6x | 1.1x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 42.9% | |
Fair Value Upside | Unlock | 11.1% | 6.2% | Unlock |